KATHERINE TESSON: Open Payments
NPI 1205561560 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 22 payments from 12 companies in 2025. Trend: 2023 $269 · 2024 $327 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 8 | $265 |
| Novo Nordisk Inc | 4 | $73 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $27 |
| Abbott Laboratories | 1 | $24 |
| Viatris Specialty LLC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Assure WCD, UPTRAVI, Rybelsus, REXULTI, Wegovy, MITRACLIP, YUPELRI, Ozempic.
Industry payments across MO — which companies pay providers there.
